African trypanosomes (Trypanosoma bnrcei) are parasitic protozoans which inhabit the mammalian host bloodstream, causing disease in humans and domestic animals in subSaharan Africa. To maintain transmission, T. bnicei must establish chronic infection, and this requires that the parasite evade the host immune response. This is achieved by a combination of antigenic variation (4) and immunosuppression. Immunosuppression has been described for all natural hosts of African trypanosomes and also for experimental rodent models, with which extensive studies have been conducted (1) . Immunosuppression can be mediated by macrophages (3, 6, 12) , and while a number of mechanisms for this effector function have been suggested (1) , in the case of murine spleen cells, nitric oxide (NO) plays a major role. High levels of NO synthesis have been observed in both splenic and peritoneal macrophages from trypanosome-infected mice (11, 13) , and NO has been shown to be directly involved in the suppression of T-cell proliferation in response to both mitogen (13) and trypanosome antigen (l1). This apparently immunosuppressive effect raises the question of whether NO plays a role in the control of trypanosome infections in vivo, because in vitro experiments have shown that NO inhibits trypanosome proliferation (15, 16) . In order to resolve this question, we examined the course of parasitemia in mice in which NO synthesis was inhibited. We also tested the susceptibility of T. bnicei to NO in vitro under conditions which were designed to take into account the physiological environment encountered by parasites in the host bloodstream.
Male C3H. diluted urine with nitrate reductase followed by the Griess assay as previously described (5) .
For in vitro experiments, T. bnwcei was grown at 37°C in a modification of the medium previously described by Baltz et al. (2) . This consisted of minimal essential medium (MEM) (Flow/ICN, Irvine, Scotland) supplemented with mM In C3H.He mice, T brncel AnTaT1.1 produces a biphasic infection, in which a parasitemic peak at about 6 days postinfection (p.i.) is followed by a partial remission and a stable parasitemia continuing until death at around 18 days p.i. Because we have previously shown in this system that production of NO by peritoneal and splenic macrophages is activated from day 3 p.i. (13), we examined the effect of treatment of infected mice with the substrate analog inhibitor of NO synthase, L-NAME (7, 10) , administered in the animals' drinking water from day 3 p.i. onwards. As controls, parallel groups of animals were treated with either the biologically inactive enantiomer D-NAME or untreated water. The level of NO synthesis was determined by monitoring urinary nitrate concentration, as has previously been carried out for murine leishmaniasis (5). The urinary nitrate concentration was significantly elevated at day 3 p.i. but was reduced to uninfected control levels in L-NAME-treated animals ( Table 1 ). Levels of nitrate in the D-NAME-treated group remained elevated and were not significantly different from those of animals receiving untreated water (not shown). Over the course of the infections, L-NAME treatment significantly reduced the parasitemia over the entire initial parasitemic wave up to day 12 p.i. (Fig. 1 [P < 0.001, two-way analysis of variance]), and peak parasitemia was reduced by over 50% (P < 0.05, Students t test). Subsequently, there was no significant difference between the two groups up to day 16 p.i., when the animals were withdrawn from the study. These data therefore suggest that T. brucei infection is not controlled by and may be exacerbated by NO production.
We next addressed the apparent contradiction presented by these data and the finding of others that growth of T. brucei was inhibited by NO in vitro (16) SNAP (100 p.M) was added to trypanosome cultures, proliferation was inhibited by 75%. However, titration of whole mouse blood into these cultures showed that, at a 1/200 dilution, the NO-mediated trypanostatic activity was totally abrogated (Fig.  2) . A similar result was obtained when murine peritoneal macrophages, activated with gamma interferon, were used as the source of NO (Table 2) . In this experiment, activated peritoneal cells produced an 88% inhibition of trypanosome proliferation which was almost totally abrogated by the addition of either L-NAME or whole blood to the cultures. In the case of L-NAME addition, the restoration of trypanosome growth is directly related to the inhibition of NO production, as evidenced by the drastically reduced accumulation of nitrite in this group. A similar reduction in nitrite accumulation was seen when a 1/200 dilution of whole blood was added to these cultures. Identical results were obtained when these in vitro experiments were repeated with independently derived clones This study provides a model system in which the in vivo inhibition of NO synthesis leads to a reduction in T. brucei parasitemia in C3H.He mice. A direct effect of the drugs used on trypanosome growth can be ruled out because extensive studies with in vitro cultures of bloodstream T brucei have shown that L-NAME and D-NAME at concentrations of up to 5 mM have no effect (data not shown). Vincendeau et al. previously showed that NO is cytostatic to T brucei (including the stock AnTaTI.1) in vitro (16) . We have confirmed their findings, but we further show that this cytostatic effect is unlikely to operate within the mammalian bloodstream. Therefore, we suggest that the reduction of parasitemia in L-NAMEtreated mice may be a consequence of inhibition of the immunosuppressive effects of NO, which has recently been shown to participate in the suppression of parasite-antigenspecific T-cell proliferative responses (11) . This is clearly different from the effect of NO in intracellular protozoan infections in which a local production of NO by macrophages would be effective against pathogens such as Leishmania spp. and Toxoplasma gondii (8) .
